5 new COVID-19 cases in Singapore; 13th consecutive day with no local infections

5 new COVID-19 cases in Singapore; 13th consecutive day with no local infections

People in masks Changi Airport (2)
People wearing face masks are seen at Singapore Changi Airport on Nov 2, 2020. (Photo: Try Sutrisno Foo)

SINGAPORE: Singapore reported five new COVID-19 cases as of noon on Monday (Nov 23), said the Ministry of Health (MOH).

All of the cases were imported and were placed on stay-home notice or isolated upon arrival in Singapore, the health ministry added. 

There were no locally transmitted cases for the 13th consecutive day.

All five imported cases were asymptomatic. They include a 16-year-old Singaporean who returned from India. 

READ: Travel bubble deferral a joint decision by Singapore and Hong Kong, says Chan Chun Sing

Another three are work permit holders currently employed in Singapore who arrived from Indonesia. 

The remaining case is a short-term visit pass holder who arrived from France. The 58-year-old man is an engineer on a work project in Singapore, said MOH.


Four more cases have been discharged from hospitals or community isolation facilities, bringing Singapore's total recoveries to 58,071. 

There are 36 COVID-19 patients still in hospital. Most of them are stable or improving, and one is in a critical condition in the intensive care unit. 

READ: Hong Kong, Singapore bubble delay highlights hurdles to travel recovery

Another 30 cases are isolated and cared for at community facilities. These are people who have mild symptoms or are clinically well but still test positive for COVID-19.

MOH said the overall number of new cases in the community has remained low, with no new cases in the past week. Further details can be found in the health ministry's daily situation report

As of Monday, Singapore has reported 58,165 COVID-19 cases and 28 fatalities from the disease.


The United States hopes to begin a sweeping programme of COVID-19 vaccinations in early December upon approval by the Food and Drug Administration, the head of the government coronavirus vaccine effort Moncef Slaoui said on Sunday.

FDA vaccine advisers reportedly will meet on Dec 10 to discuss approving vaccines which pharmaceutical firms Pfizer and Moderna say are at least 95 per cent effective.

READ: Vaccine will not be enough to stop COVID-19 pandemic: WHO chief

Britain could also give regulatory approval to Pfizer-BioNTech's COVID-19 vaccine this week, even before the US authorises it, the Telegraph news site reported.

Citing government sources, it said British regulators were about to start a formal appraisal of the vaccine, and that the National Health Service had been told to be ready to administer it by Dec 1.

G20 leaders said on Sunday they will "spare no effort" to ensure the fair distribution of coronavirus vaccines worldwide, and support poor countries whose economies have been ravaged by the crisis.

The novel coronavirus has killed at least 1.3 million people and infected more than 58 million since the outbreak emerged in China last December.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: CNA/jt/zl